Literature DB >> 28966787

A stitch in time: 3-monthly long-acting injectable paliperidone palmitate in schizophrenia.

Mark Taylor1, Hannah Chu-Han Huang2.   

Abstract

Entities:  

Year:  2017        PMID： 28966787      PMCID： PMC5606343          DOI： 10.1177/2045125317721874

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN： 2045-1253


× No keyword cloud information.
  8 in total

Review 1.  Attitudes of patients and mental health staff to antipsychotic long-acting injections: systematic review.

Authors:  Linda Waddell; Mark Taylor
Journal:  Br J Psychiatry Suppl       Date:  2009-11

Review 2.  Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review.

Authors:  David Taylor
Journal:  Br J Psychiatry Suppl       Date:  2009-11

Review 3.  Should long-acting (depot) antipsychotics be used in early schizophrenia? A systematic review.

Authors:  Mark Taylor; Ka Ying Bonnie Ng
Journal:  Aust N Z J Psychiatry       Date:  2012-12-03       Impact factor: 5.744

4.  Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.

Authors:  Cherrie Galletly; David Castle; Frances Dark; Verity Humberstone; Assen Jablensky; Eóin Killackey; Jayashri Kulkarni; Patrick McGorry; Olav Nielssen; Nga Tran
Journal:  Aust N Z J Psychiatry       Date:  2016-05       Impact factor: 5.744

5.  Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial.

Authors:  Kenneth L Subotnik; Laurie R Casaus; Joseph Ventura; John S Luo; Gerhard S Hellemann; Denise Gretchen-Doorly; Stephen Marder; Keith H Nuechterlein
Journal:  JAMA Psychiatry       Date:  2015-08       Impact factor: 21.596

6.  A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.

Authors:  Jari Tiihonen; Jari Haukka; Mark Taylor; Peter M Haddad; Maxine X Patel; Pasi Korhonen
Journal:  Am J Psychiatry       Date:  2011-03-01       Impact factor: 18.112

Review 7.  "First do no harm." A systematic review of the prevalence and management of antipsychotic adverse effects.

Authors:  Su Ling Young; Mark Taylor; Stephen M Lawrie
Journal:  J Psychopharmacol       Date:  2014-12-16       Impact factor: 4.153

8.  Antipsychotic long-acting injections: mind the gap.

Authors:  Maxine X Patel; Mark Taylor; Anthony S David
Journal:  Br J Psychiatry Suppl       Date:  2009-11
  8 in total
  1 in total

1.  Oral and Palmitate Paliperidone Long-Acting Injectable Formulations' Use in Schizophrenia Spectrum Disorders: A Retrospective Cohort Study from the First Episode Psychosis Intervention Program (CRUPEP).

Authors:  R Segarra; M Recio-Barbero; M Sáenz-Herrero; O Mentxaka; J Cabezas-Garduño; J I Eguíluz; L F Callado
Journal:  Int J Neuropsychopharmacol       Date:  2021-09-21       Impact factor: 5.176
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.